@article{c58704f8542f4281bc3c8d1f1e198346,
title = "Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma",
author = "Hira Mian and Grant, \{Shakira J.\} and Monika Engelhardt and Charlotte Pawlyn and Sara Bringhen and Sonja Zweegman and Stege, \{Claudia A.M.\} and Rosko, \{Ashley E.\} and \{von Lilienfeld-Toal\}, Marie and Wildes, \{Tanya M.\}",
note = "Funding Information: ME: Grant support from German Cancer Aid (DKH). Funding Information: SJG:receives research support from National Heart Lung and Blood Institute (Grant No: 5T32HL007093 ), PI: Janis L. Abkowitz. Funding Information: Dr. Kah Poh (Melissa) Loh for her Editorial review. >[Table presented], HM: Honoraria/Consultancy fees: Amgen, Celgene, Takeda, Janssen, Sanofi. SJG:receives research support from National Heart Lung and Blood Institute (Grant No: 5T32HL007093), PI: Janis L. Abkowitz. ME: Grant support from German Cancer Aid (DKH). CP: Honoraria/Consultancy fees: Amgen, Celgene, Takeda, Janssen. SB: reports honoraria from Amgen, Bristol-Myers Squibb, Celgene, and Janssen; and reports a consultancy/advisory role for Celgene, Janssen, Karyopharm, and Takeda. SZ: research support from Janssen, Celgene and Takeda; serves in advisory boards for Janssen, Celgene and Takeda. CS: No conflicts reported. AR: Research Funding: Janssen, Regeneron, Millenium., MLT: Honoraria/Consulting fees: Celgene, Janssen, Takeda, Amgen, Oncopeptides, Cancer Drug Development Forum, Gilead, Merck, BMS, Research Funding: Celgene, Gilead, Novartis, Deutsche Krebshilfe (German Cancer Aid). TW: Research Funding: Janssen; Consulting: Carevive Systems, Seattle Genetics.",
year = "2020",
month = jun,
doi = "10.1016/j.jgo.2020.04.008",
language = "English",
volume = "11",
pages = "764--768",
journal = "Journal of Geriatric Oncology",
issn = "1879-4068",
number = "5",
}